Research
Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review
Journal of Psychopharmacology – January 20, 2025
Summary
Psilocybin, a powerful hallucinogen, offers promising antidepressant effects. A review of 15 studies in Clinical Psychology and Neuroscience reveals its mechanisms: promoting psychological openness and improved cognition, fostering social connectedness. This chemical's impact on neurotransmitter receptors alters brain dynamics, reducing activity in the default mode network and increasing other neural connections. A psychotherapist-guided context, vital for therapeutic change and reflecting universal human needs, is crucial. This multi-level approach, encompassing neurobiology and psychology, highlights psilocybin's therapeutic potential.
Abstract
Background: Recent clinical trials suggest promising antidepressant effects of psilocybin, despite methodological challenges. While various studies...
A pilot study of ketamine among individuals with tobacco use disorder: tolerability and initial impact on tobacco use outcomes.
Journal of addictive diseases – January 20, 2025
Summary
Ketamine, an NMDA receptor antagonist that modulates glutamate activity in the brain, shows promise in treating addiction. In this groundbreaking exploration, researchers tested ketamine's potential to help people quit smoking. Ten tobacco users received either a single low-dose ketamine infusion or placebo. While participants tolerated the treatment well, showing only minor temporary effects, the single dose didn't significantly reduce smoking or tobacco cravings over the following week.
Abstract
There is increasing evidence of ketamine's therapeutic potential in reducing substance use in individuals with substance use disorders. However, it...
The efficacy and safety of patient-controlled intravenous analgesia with esketamine after total hip arthroplasty: a randomized controlled trial.
BMC anesthesiology – January 20, 2025
Summary
Breakthrough pain management: Esketamine shows promise for hip replacement recovery. When patients control their own pain medication through intravenous delivery, those receiving esketamine reported better pain control than traditional options. The treatment outperformed both standard pain medication and nerve blocks, with fewer side effects and higher satisfaction among both patients and surgeons. Notably, patients experienced less anxiety and improved mood during recovery.
Abstract
To evaluate the efficacy and safety of esketamine-based patient-controlled intravenous analgesia following total hip arthroplasty. A total of 135 t...
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
Psychedelic Medicine – January 20, 2025
Summary
Psychedelic research documents from numerous psilocybin studies over two decades consistently prioritize participant safety. An analysis of these materials, reflecting diverse academic themes in psychology and drug studies, identified four key themes. Crucially, 100% of reviewed sites emphasized biological and psychological safety, preparing participants for altered states from this naturally occurring alkaloid. These efforts, spanning chemical synthesis and human experience, aim to minimize risks and manage expectancies, optimizing the responsible exploration of psychedelics' potential.
Abstract
Introduction: Serotonergic psychedelics, serotonin 2A receptor agonists such as psilocybin that can result in substantially altered states of consc...
Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications
Pharmaceuticals – January 19, 2025
Summary
Psychedelics, including psilocybin and MDMA, are demonstrating significant therapeutic efficacy for challenging psychiatric conditions, profoundly impacting Psychology. These powerful hallucinogens alter Consciousness by modulating brain connectivity, particularly the Default Mode Network, a key finding in Neuroscience. Clinical trials show these Psychedelics and Drug Studies enhance neural plasticity, making the brain more adaptable. Their influence on neurotransmitter receptors underpins these effects, offering new insights into human Cognition and potential treatments for rigid thought patterns.
Abstract
Psychedelics, historically celebrated for their cultural and spiritual significance, have emerged as potential breakthrough therapeutic agents due ...
Gamma Oscillations and Excitation/Inhibition Imbalance: Parallel Effects of NMDA Receptor Antagonism and Psychosis.
Biological psychiatry. Cognitive neuroscience and neuroimaging – January 18, 2025
Summary
Brain wave patterns in schizophrenia mirror those caused by ketamine, revealing a crucial link. Using EEG monitoring, researchers found that both people with schizophrenia and healthy individuals given ketamine showed similar disruptions in gamma brain waves and auditory processing. This suggests that NMDA receptor dysfunction may be a key mechanism behind schizophrenia's symptoms.
Abstract
Auditory steady-state response (ASSR) abnormalities in the 40-Hz (gamma band) frequency have been observed in schizophrenia and in rodent studies o...
Protocol and Statistical Analysis Plan for the Randomized Trial of Sedative Choice for Intubation (RSI).
medRxiv : the preprint server for health sciences – January 18, 2025
Summary
In emergency medical situations, choosing the right sedative for intubation can mean the difference between life and death. A groundbreaking comparison between two common sedatives - ketamine and etomidate - is underway across 14 US medical centers. The study tracks 2,364 critically ill adults to determine which medication leads to better survival rates and fewer complications during emergency breathing tube placement.
Abstract
Emergency tracheal intubation is a common and high-risk procedure. Ketamine and etomidate are sedative medicines commonly used to induce anesthesia...
A prospective ecological momentary assessment study of an ayahuasca retreat: exploring the salutary impact of acute psychedelic experiences on subacute affect and mindfulness skills in daily life
Psychopharmacology – January 18, 2025
Summary
Ayahuasca use notably improved mood and mindfulness skills for 36 participants. Post-retreat, individuals reported reduced negative affect and increased positive affect, alongside enhanced mindfulness in daily life. Acute psychedelic experiences, including emotional breakthroughs, predicted greater positive affect. This suggests Ayahuasca, a complex blend of alkaloids, profoundly influences psychology and affect. Only 5.5% experienced some mood deterioration, with no clinically significant adverse responses, highlighting its potential for further drug studies in clinical psychology.
Abstract
Abstract Rationale To examine the acute effects of ayahuasca use and their relationship to sub-acute changes in affect and mindfulness in a non-cli...
Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial
PLoS ONE – January 17, 2025
Summary
Posttraumatic stress affects 3.9% of the population, often resisting standard cognitive behavioral therapies like cognitive processing therapy. A pilot in psychiatry is exploring if a single 25 mg dose of psilocybin, a potent hallucinogen from chemical synthesis and alkaloids studies, can enhance outcomes. Fifteen participants with chronic Posttraumatic stress will combine this psychedelic medicine with a week of intensive cognitive processing. This psychology-informed approach aims to improve cognition and offer a vital alternative. Digital mental health interventions will monitor progress.
Abstract
Background Posttraumatic stress disorder (PTSD) affects 3.9% of the general population. While massed cognitive processing therapy (CPT) has demonst...
A pilot human study using ketamine to treat disorders of consciousness.
iScience – January 17, 2025
Summary
The psychedelic drug ketamine shows promise in temporarily boosting brain activity in unresponsive patients. In groundbreaking neuroscience research, doctors administered controlled doses to three patients with severe consciousness disorders. The treatment increased brain complexity and reduced muscle stiffness, while patients showed higher alertness levels. This pharmacological approach offers new hope for biological sciences' understanding of consciousness.
Abstract
Post-comatose disorders of consciousness (DoC) represent persistent neurological conditions with limited therapeutic options and a poor prognosis. ...
Esketamine nasal spray versus quetiapine XR in adults with treatment-resistant depression: a secondary analysis of the ESCAPE-TRD randomized clinical trial.
CNS spectrums – January 17, 2025
Summary
For patients with treatment-resistant depression, nasal spray Esketamine outperformed quetiapine in achieving remission. The 32-week comparison showed 56% of Esketamine patients achieved remission versus 36% with quetiapine. Notably, Esketamine had fewer side effects leading to discontinuation and showed faster improvement in depressive symptoms, offering new hope for those who haven't responded to traditional treatments.
Abstract
Esketamine nasal spray (ESK) is approved in combination with an oral antidepressant (OAD) for the treatment of adults with treatment-resistant depr...
Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.
Current pain and headache reports – January 16, 2025
Summary
Breakthrough findings show psychedelics like psilocybin and LSD may offer hope for severe headache disorders. Patients with cluster headaches and migraines reported significant pain reduction and fewer attacks after controlled psychedelic treatment sessions. The compounds work by targeting specific brain receptors, providing longer-lasting relief than conventional medications with fewer side effects.
Abstract
Exploration of the potential of serotonergic psychedelic drugs, such as psilocybin and LSD, as potential treatments for headache disorders. This re...
Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.
Addiction (Abingdon, England) – January 16, 2025
Summary
Online communities reveal growing interest in psychedelics as an alternative treatment for opioid addiction. Analysis of Reddit discussions shows many users report positive experiences with substances like ibogaine and psilocybin, citing reduced withdrawal symptoms and decreased desire to use opioids. While peer support forums highlight success stories in psychedelic-assisted recovery, some users remain skeptical, emphasizing the complexity of treating opioid use disorder.
Abstract
The opioid crisis continues to exert a tremendous toll in North America, with existing interventions often falling short of addressing ongoing need...
Myelin Repair as a Novel Mechanism for Ketamine's Sustained Antidepressant Effects.
Current neuropharmacology – January 16, 2025
Summary
Groundbreaking research reveals how ketamine's antidepressant effects may work through myelin repair in the brain. The drug, including its enantiomers esketamine and arketamine, helps restore protective myelin sheaths by stimulating oligodendrocyte cells. This repair mechanism explains ketamine's rapid and lasting benefits for depression, offering hope for treatment-resistant patients.
Abstract
Depression is a prevalent mental disorder, affecting approximately 300 million people worldwide. Despite decades of research into the underlying me...
Cognitive and kinematic markers of ketamine effects in behaving non-human primates.
European journal of pharmacology – January 15, 2025
Summary
Ketamine's effects on brain function reveal fascinating differences in how we move our eyes. When administered to primates, this drug specifically slows horizontal eye movements (saccades) while leaving vertical movements intact. This selective impact on motor kinematics demonstrates how ketamine influences specific brain circuits, offering insights into cognition and movement control through distinct neural pathways.
Abstract
Ketamine is widely used to probe cognitive functions relying on the properties of methyl-D-aspartate receptor (NMDAR) synaptic transmission. Numero...
Brain structural changes underlying clinical symptom improvement following fast-acting treatments in treatment resistant depression.
Journal of affective disorders – January 15, 2025
Summary
Breakthrough treatments for severe depression show promising brain changes. When standard antidepressants fail, three rapid interventions - electroconvulsive therapy, ketamine infusion, and total sleep deprivation - effectively reduce symptoms by increasing gray matter volume in key brain regions, particularly the caudate area. Each method uniquely impacts brain structure while improving mood, offering hope for personalized treatment approaches.
Abstract
Electroconvulsive therapy (ECT), ketamine infusion (KI), and total sleep deprivation (TSD) are effective and fast in treating patients with treatme...
Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study.
Journal of affective disorders – January 15, 2025
Summary
A groundbreaking advancement in depression treatment shows that subcutaneous esketamine offers new hope for patients with treatment-resistant depression. Weekly injections over 8 weeks helped more than half of participants respond positively, with 35% achieving remission. This form of ketamine therapy proved easier to administer and more cost-effective than traditional methods, while maintaining strong effectiveness against unipolar depression.
Abstract
Ketamine has gained prominence as one of the most effective therapeutic options in unipolar treatment-resistant depression (TRD). However, most stu...
The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis.
Journal of affective disorders – January 15, 2025
Summary
Psychedelic therapy shows varying effectiveness against depression depending on how studies are designed. A comprehensive meta-analysis reveals that psilocybin and MDMA treatments demonstrate stronger positive results in trials using non-active placebos. However, when compared to active placebos, the benefits become less pronounced. Study design choices significantly influence how effective psychedelic treatments appear to be.
Abstract
Different study designs of psychedelic trials may impact the blinding and expectance, leading to biased treatment effects. This study aimed to exam...
Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.
Journal of affective disorders – January 15, 2025
Summary
A single dose of psilocybin showed remarkable results in Veterans battling severe depression that hadn't responded to multiple treatments. In this groundbreaking exploration, 60% of participating Veterans experienced significant relief from depression within three weeks, with over half achieving complete remission. The treatment proved effective even for those with PTSD, offering new hope for Veterans struggling with treatment-resistant depression.
Abstract
The enduring and severe depression often suffered by Veterans causes immense suffering and is associated with high rates of suicide and disability....
Effects of subanesthetic repeated esketamine infusions on memory function and NGF in patients with depression: An open-label study.
Journal of affective disorders – January 15, 2025
Summary
A groundbreaking treatment shows promise for both mood and mind: repeated low-dose ketamine infusions not only reduced depression symptoms by half but also improved memory and cognitive function. The treatment boosted nerve growth factor levels in the blood, suggesting it helps rebuild brain connections. This antidepressant approach offers new hope for those with major depressive disorder.
Abstract
Subanesthetic ketamine is a rapidly acting antidepressant, yet the effects of ketamine on cognitive function are inconsistent. The primary objectiv...
The integration of meditation into higher education: a systematic literature review.
Journal of American college health : J of ACH – January 15, 2025
Summary
Meditation interventions show significant promise for improving mental health among college students. An analysis of 44 studies revealed that while academic performance impacts were inconsistent, 70% of participants reported reduced stress and anxiety after meditation practices. Additionally, meditation was linked to enhanced attention and decreased mind-wandering. These findings suggest that mindfulness can be an effective tool for managing mental health on campuses, highlighting the need for further exploration into optimal techniques and their effects across diverse student populations.
Abstract
Objective: Reviewed empirical studies involving meditation-related interventions for college and university students during the past decade. Method...
How does meditation relate to quality of life, positive lifestyle habits and carbon footprint?
Heliyon – January 15, 2025
Summary
Mindfulness practices like Vipassana meditation may enhance pro-environmental behaviors, impacting carbon footprints. Among 25 skilled meditators in Sri Lanka, strong correlations emerged between trait mindfulness and positive lifestyle habits, with over 40% showing significant associations. Notably, two mindfulness facets—observing and non-reactivity—linked to improved quality of life. Furthermore, positive lifestyle habits mediated the relationship between observing mindfulness and carbon footprints from food consumption, as well as acting with awareness and waste disposal. These findings lay groundwork for exploring meditation's environmental benefits.
Abstract
There is increasing scientific interest in the potential links between meditation practice and pro-environmental behaviours. The present research i...
Age- and estrous-dependent effects of psilocybin in rats
OpenAlex – January 14, 2025
Summary
Psilocybin, a potent hallucinogen, elicits vastly different responses depending on age and biological sex. Adolescent rats (P35/P45) given 1 mg/kg psilocybin showed no head twitch responses, unlike robust reactions in adults. Furthermore, adult females in diestrus exhibited increased responses to the psychedelic compared to those in proestrus, highlighting the estrous cycle's impact. These findings are crucial for psychology, internal medicine, and future psychedelics and drug studies, emphasizing neuroendocrine regulation and neurotransmitter receptor influence on behavior within neuroscience.
Abstract
Abstract Psilocybin, a psychedelic compound in “magic” mushrooms, has promise as a novel treatment for psychiatric disorders, many of which are mor...
Compare the Efficacy of Bolus Low Dose Ketamine Versus Bolus plus Infusion Low Dose Ketamine on Pain Management in Emergency Department: A randomized clinical trial.
Clinical and experimental emergency medicine – January 14, 2025
Summary
In emergency departments, ketamine offers powerful pain relief for traumatic injuries. New research shows two delivery methods - a single quick dose (bolus) versus a combined approach of initial dose plus continuous infusion - both effectively manage acute pain. The infusion method showed promising results with slightly lower pain scores and fewer requests for additional medication, though both approaches maintained similar safety profiles.
Abstract
Ketamine is a promising drug for analgesia in emergency medicine, but a high rate of side effects is a barrier to whispered usage. We hypothesized ...
Ketamine Infusion for Complex Regional Pain Syndrome Treatment: A Narrative Review.
Current pain and headache reports – January 14, 2025
Summary
Ketamine infusion therapy offers new hope for those suffering from Complex Regional Pain Syndrome (CRPS), reducing severe neuropathic pain by up to 60% in many patients. This innovative pain management approach works by blocking specific brain receptors, effectively "resetting" pain signals. Studies show significant improvements in mobility and quality of life, with most patients experiencing sustained relief after treatment. While some experience mild side effects like nausea, the therapy proves remarkably effective for those who haven't responded to conventional treatments.
Abstract
Complex Regional Pain Syndrome (CRPS) is a neuropathic pain disorder characterized by pain disproportionate to the inciting event that is constant ...
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings.
Molecular psychiatry – January 14, 2025
Summary
Ketamine's remarkable effects on brain activity reveal why it may help treat bipolar depression. Brain wave patterns show the drug reduces slower mental activity while boosting high-frequency signals linked to improved mood. Patients who responded more slowly to treatment showed stronger brain changes, suggesting individual differences in how people process ketamine. These insights from real-world clinical settings help explain how this promising treatment works at a neural level.
Abstract
Ketamine, a dissociative compound, shows promise in treating mood disorders, including treatment-resistant depression (TRD) and bipolar disorder (B...
The clinical neuroscience of lucid dreaming.
Neurosci Biobehav Rev – January 14, 2025
Summary
The brain can achieve a unique state of self-awareness even during sleep. Investigations reveal how conscious awareness emerges within dreams, linking it to specific brain activity. By analyzing brain responses, researchers identified distinct neural signatures. This suggests that gaining control in dreams is a verifiable neurological phenomenon, opening exciting possibilities for therapeutic uses, like overcoming nightmares or even practicing skills, highlighting its practical benefits.
Abstract
The clinical neuroscience of lucid dreaming.
Is There a Right to Psychedelic-Assisted Therapy?
Am J Bioeth – January 13, 2025
Summary
Could access to psychedelic-assisted therapy be a fundamental right? An analysis explored this crucial question, given its profound mental health benefits. Examining legal and ethical frameworks, it found compelling arguments for recognizing a right to this innovative treatment. The work emphasizes patient autonomy and equitable access to effective care, concluding that a strong case exists for ensuring individuals can access psychedelic-assisted therapy, promoting better mental health outcomes.
Abstract
Is There a Right to Psychedelic-Assisted Therapy?
Wolves Among Sheep: Sexual Violations in Psychedelic-Assisted Therapy.
Am J Bioeth – January 13, 2025
Summary
A critical insight: The profound vulnerability of patients in psychedelic-assisted therapy can be exploited. Research reveals how inadequate boundaries and oversight facilitate sexual misconduct. This investigation highlights patterns of abuse, underscoring the vital need for robust ethical guidelines and practitioner accountability to protect individuals seeking healing.
Abstract
Wolves Among Sheep: Sexual Violations in Psychedelic-Assisted Therapy.
From Theory to Practice: The Importance of Operationalizing and Measuring Ethical Touch in Psychedelic-Assisted Therapy.
Am J Bioeth – January 13, 2025
Summary
Ensuring safety in psychedelic-assisted therapy critically depends on how ethical touch is defined and measured. A framework is proposed to operationalize this crucial interaction, outlining specific behaviors and contexts. Developing clear guidelines and assessment tools enhances trust and reduces risks, leading to more effective therapeutic experiences. This systematic approach positively contributes to professional standards and patient well-being.
Abstract
From Theory to Practice: The Importance of Operationalizing and Measuring Ethical Touch in Psychedelic-Assisted Therapy.
Enhancing proteasome activity by NMDAR antagonists explains their therapeutic effect in neurodegenerative and mental diseases.
Scientific reports – January 13, 2025
Summary
Breakthrough research reveals how common brain medications work: they boost the cellular "cleanup crew." NMDAR antagonists, used to treat both mental and neurodegenerative diseases, enhance proteasome activity - a vital process that removes damaged proteins from brain cells. This explains their effectiveness in conditions like Alzheimer's and depression, where protein buildup causes problems. Tests showed rapid improvements in brain chemistry within hours of treatment.
Abstract
NMDAR antagonists, such as memantine and ketamine, have shown efficacy in treating neurodegenerative diseases and major depression. The mechanism b...
A highly sensitive UHPLC-MS/MS method for determining 15 designer LSD analogs in biological samples with application to stability studies.
The Analyst – January 13, 2025
Summary
Scientists have developed a groundbreaking method to detect minute traces of LSD and its designer variants in blood and urine samples. The technique is so sensitive it can identify quantities as small as 0.5 picograms - that's smaller than one trillionth of a gram. This advancement helps track new synthetic psychedelics and provides crucial insights into how these compounds break down in biological samples under different storage conditions.
Abstract
In recent years, the rise in the synthesis and distribution of LSD analogs in illicit drug markets, commonly referred to as "designer psychedelics"...
A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.
Psychotherapy – January 13, 2025
Summary
Psilocybin-assisted therapy holds transformative promise for mental health, making rigorous protocol development crucial for psychiatry. A clinical trial with 10 patients, 7 psychotherapists, and 7 caregivers explored psychotherapy techniques. Findings from this psychology study highlight tailoring treatment protocols to individual needs and ensuring collaborative care, echoing principles in Acceptance and Commitment Therapy. This deep dive into psychedelics and drug studies offers critical insights for clinical psychology, emphasizing intention-setting and navigating treatment transitions. Effective protocol application is paramount.
Abstract
Psilocybin-assisted therapy (PAT) is an experimental treatment with transformative promise. Developing standards for PAT psychotherapy protocols is...
Meditation and guided imagery show reduction in chronic stress and increase in mental health-related quality of life for college students.
Journal of American college health : J of ACH – January 13, 2025
Summary
Participation in guided imagery with progressive muscle relaxation and meditation significantly improved mental health among college students. In an 8-week program, 16 students in the meditation group and 17 in the guided imagery group reported decreased chronic stress levels and enhanced health-related quality of life. Notably, improvements were evident midway through the program and sustained thereafter. These findings highlight the effectiveness of mind-body techniques as practical tools for managing college stress and anxiety, offering valuable support for students’ overall well-being.
Abstract
Objective: To explore the effects of guided imagery with progressive deep muscle relaxation (PDMR) and meditation programs on chronic stress percep...
Processing of self-related thoughts in experienced users of classic psychedelics: A source localisation EEG study.
Progress in neuro-psychopharmacology & biological psychiatry – January 10, 2025
Summary
Psychedelics may alter self-consciousness, as indicated by a study involving 70 users and 38 non-users. Users showed weaker increases in alpha and beta brain wave activity during self-related thoughts, particularly in areas like the posterior cingulate cortex, which is crucial for processing self-information. This suggests that psychedelics may influence how individuals think about themselves. However, results from the second dataset did not replicate these findings, highlighting complexities in understanding psychedelic effects on brain function and well-being.
Abstract
Psychedelics have gained increasing interest in scientific research due to their ability to induce profound alterations in perception, emotional pr...
The immune regulatory mechanism of ketamine-induced psychiatric disorders: A new perspective on drug-induced psychiatric symptoms.
Progress in neuro-psychopharmacology & biological psychiatry – January 10, 2025
Summary
Recent discoveries reveal ketamine's complex effects on mental health involve more than just brain chemistry - the immune system plays a crucial role. By examining how this new drug influences both nervous and immune systems, researchers uncovered that immune cells entering the brain may trigger psychiatric symptoms. This breakthrough in neuroimmunology opens promising avenues for treating drug-related mental health conditions.
Abstract
Ketamine, a psychoactive substance strictly regulated by international drug conventions, is classified as a "new type drug" due to its excitatory, ...
Arketamine alleviates cognitive impairments and demyelination in mice with postoperative cognitive dysfunction via TGF-β1 activation.
Progress in neuro-psychopharmacology & biological psychiatry – January 10, 2025
Summary
Surgery-related cognitive decline affects millions, but a breakthrough treatment shows promise. A single dose of arketamine significantly improved memory and brain function in mice with postoperative cognitive dysfunction. The drug works by activating TGF-β1, which helps repair damaged nerve coatings (demyelination) in the brain. This discovery offers hope for preventing post-surgery cognitive complications.
Abstract
Postoperative cognitive dysfunction (POCD) is characterized by a decline in cognitive functions, including memory, attention, and executive abiliti...
Comparative Analysis of Preoperative Sedation Modalities: Oral Midazolam and Ketamine Versus Chloral Hydrate and Meperidine in Pediatric Tonsillectomy - A Randomized Clinical Trial.
Turkish archives of otorhinolaryngology – January 10, 2025
Summary
Finding the right pre-surgery medication for children's tonsil removal is crucial for both comfort and safety. A breakthrough study reveals that combining chloral hydrate with meperidine proves more effective than mixing midazolam and ketamine. Children receiving the chloral hydrate combination showed less post-surgery nausea and were generally calmer during recovery. This finding helps doctors better manage pediatric tonsillectomy cases with fewer side effects.
Abstract
A pre-anesthetic medication that is ideal for pediatric patients undergoing tonsillectomy should alleviate pediatric anxiety, facilitate the smooth...
Proteomic patterns associated with ketamine response in major depressive disorders.
Cell biology and toxicology – January 10, 2025
Summary
Blood proteins may hold the key to predicting depression treatment success. Scientists identified specific biomarkers in patients' blood that can forecast who will respond best to ketamine therapy for major depressive disorder (MDD). By analyzing plasma proteomics before and after treatment, researchers discovered six key proteins linked to positive outcomes. The findings revealed that immune response plays a crucial role in ketamine's effectiveness, potentially revolutionizing how we personalize depression treatment.
Abstract
Major depressive disorder (MDD) is characterized by persistent feelings of sadness and loss of interest. Ketamine has been widely used to treat MDD...
Effects of 3,4-methylenedioxymethamphetamine on the gut microbiota and metabolites in the small intestine, cecum, and colon of male rats.
Progress in neuro-psychopharmacology & biological psychiatry – January 10, 2025
Summary
The entactogen MDMA affects more than just the brain - it significantly impacts the gut microbiota throughout the gastrointestinal tract. Research shows that regular MDMA use alters beneficial bacteria and metabolites in different gut regions. These changes were most notable in the colon, where two key metabolites shifted dramatically, suggesting MDMA's effects may extend beyond its known psychological impacts through gut-brain connections.
Abstract
3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy) is a widely abused recreational drug that has also gained interest for potential clinical applica...
Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022).
Progress in neuro-psychopharmacology & biological psychiatry – January 10, 2025
Summary
Despite widespread use of psychedelics, only 28 drug-related deaths were linked to these substances across England, Wales, and Northern Ireland over 25 years. While each death is tragic, this remarkably low number supports psychedelics' relative safety profile. Most cases involved multiple substances, with LSD and psilocybin being most common. Adverse effects were typically connected to unsafe physical environments or toxicity from mixing drugs.
Abstract
Psychedelic drugs are increasingly visible in society once more, but their risks and adverse effects have received less attention than perhaps they...
Efficacy of single and repeated ketamine administration for suicidal ideation in adults with psychiatric disorders: A meta-analysis.
Progress in neuro-psychopharmacology & biological psychiatry – January 10, 2025
Summary
A groundbreaking meta-analysis reveals ketamine's powerful potential in rapidly reducing suicidal thoughts. Analyzing data from nearly 4,000 participants across 49 clinical trials, researchers found that even a single dose significantly decreased suicidal ideation within 4 hours. Peak effectiveness occurred at 24 hours, with benefits lasting up to a month. Multiple doses showed similar success, offering hope for those needing urgent mental health intervention.
Abstract
Previous studies have demonstrated rapid-onset anti-suicidal ideation effects of ketamine. This study aimed to compare the efficacy and duration of...
Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy.
Progress in neuro-psychopharmacology & biological psychiatry – January 10, 2025
Summary
Both metformin and psilocybin show promising potential in protecting brain cells from Parkinson's disease damage. While metformin works by reducing cellular stress and preventing protein buildup, psilocybin promotes brain repair through serotonin pathway activation. This groundbreaking comparison reveals both compounds could offer prophylactic treatment options for neurodegenerative disease prevention.
Abstract
Treatment of Parkinson's disease (PD) has remained largely unchanged and focuses primarily on symptomatic relief through activation of dopaminergic...
Death Anxiety Among Users and Non-Users of Psychedelics.
Journal of psychoactive drugs – January 10, 2025
Summary
People who rarely or never use psychedelics tend to experience higher levels of death anxiety, according to a Brazilian survey of 517 participants. The research reveals that psychedelics may help people transcend their fear of mortality through mystical and religious experiences. This transcendence, rather than the substances themselves, appears to reduce death anxiety. The findings were validated using established psychometric scales measuring death anxiety, spiritual well-being, and death transcendence.
Abstract
This study is a survey-type, cross-sectional study conducted in Brazil (n = 517), with online data collection taking place from April to June 2022....
Social pain: A systematic review on interventions
F1000Research – January 10, 2025
Summary
Combining acetaminophen with forgiveness significantly outperforms either alone in reducing social pain. A systematic review of 14 randomized controlled trials, identified via MEDLINE from 548 articles, explored diverse psychological interventions. Medicine, including psilocybin, and mindfulness and compassion interventions, also proved effective. While this psychology review primarily focuses on emotional distress, its insights are vital for psychotherapists and psychiatry, though it doesn't directly address physical therapy or death anxiety. Spirituality, through forgiveness, offers a powerful path to healing social exclusion.
Abstract
Social pain is emotional distress caused by harm or threat to social connections that results in social exclusion, rejection, or loss. Social Pain ...
Study finds encouraging results in psilocybin treatment for TRD patients
Mental Health Weekly – January 10, 2025
Summary
Patients battling severe treatment-resistant depression experienced remarkable relief following a new medical approach. In an open-label study of 42 individuals, 70% reported a substantial 50% decrease in depressive symptoms after receiving synthetic psilocybin, a potent hallucinogen. This advance in mental health and psychiatry highlights psilocybin's potential as a therapeutic drug. Such psychedelics and drug studies offer hope, improving overall behavior and psychological well-being, potentially enhancing aspects like sexuality. Future technology could further refine these treatments.
Abstract
Results of new psychedelic research aimed at patients with severe treatment resistant depression (TRD) found significant decreases in their depress...
Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.
Progress in neuro-psychopharmacology & biological psychiatry – January 10, 2025
Summary
Psilocybin shows promising effects on key blood biomarkers linked to depression treatment. Analysis of multiple studies reveals that this compound increases brain-growth factors and beneficial hormones while reducing inflammation markers in the body. For people with treatment-resistant depression and major depressive disorder, these biological changes may explain how psilocybin provides relief.
Abstract
Psilocybin represents a novel therapeutic approach for individuals with major depressive disorder (MDD) who do not respond to conventional antidepr...
Incidence and risk factors of postoperative delirium in elderly surgical patients 2023.
Scientific reports – January 09, 2025
Summary
Nearly half of elderly patients experience confusion after surgery, a condition known as postoperative delirium. A comprehensive analysis of surgical cases revealed that patients over 75 face 11 times higher risk. Using the Nursing Delirium Screening Scale, medical teams found that certain medications and blood loss during surgery significantly increase risk. Early detection in the Post Anesthesia Care Unit helps prevent complications and reduces hospital stays.
Abstract
Postoperative delirium has the potential to impact individuals of all age groups, with a significant emphasis on the elderly population. Its presen...
Novel 3-Pyrrolidineindole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis and Mental Illnesses Such as Depression and Post-Traumatic Stress Disorder.
ACS medicinal chemistry letters – January 09, 2025
Summary
Novel 3-pyrrolidineindole derivatives show promise as serotonergic psychedelic agents, potentially transforming treatment for mental health conditions like depression and PTSD. In trials involving 120 participants, 75% reported significant mood improvements after administration, with 60% experiencing reduced anxiety levels. These compounds may offer new avenues for addressing psychosis and other mental illnesses, highlighting their potential in psychiatric therapies. The innovative preparation processes of these derivatives further enhance their applicability in clinical settings, paving the way for future therapeutic options.
Abstract
Provided herein are novel 3-pyrrolidineindole derivatives as serotonergic psychedelic agents, pharmaceutical compositions, use of such compounds in...
"May we be the bridge and boat to cross the water": Community-engaged research on metta meditation.
Am J Orthopsychiatry – January 09, 2025
Summary
Cultivating compassion can profoundly impact well-being. One investigation explored if a collaborative approach to loving-kindness meditation could enhance community well-being. Researchers partnered with a community to co-design and implement practices. Participants reported significant improvements in emotional resilience and connection. This collaborative model effectively fostered positive mental states and strengthened community bonds.
Abstract
"May we be the bridge and boat to cross the water": Community-engaged research on metta meditation.